foxo4-dri senolytic peptide human trial 2024 Frontiers Frontiers | Senolytic Peptide FOXO4-DRI
Description
Satiety hormone signaling studies
This process normalizes activated astrocytes, enhances A clearance, and alleviates oxidative stress and neuroinflammation (Lei et al., 2024)
Instead of simply appending a non-a-amino long straight chain amino acid to the N-terminal we chose to eliminate the N-terminal amine entirely, which increased overall hydrophobicity and removed a critical hydrogen bonding site
Rosenberg, S.W
